bit.bio defends European patent for ‘novel’ opti-ox technology
The EPO ruling affirms bit.bio’s European patent for opti-ox, its proprietary stem cell engineering technology. Credit: Yavdat/ Shutterstock bit.bio has successfully defended the European patent for its opti-ox cell programming technology. After a hearing held on 25 September 2024, the […]
bit.bio defends European patent for ‘novel’ opti-ox technology Read More »